Organigram Global Inc. (TSX: OGI) Stock Analysis & Fundamentals

OGIOrganigram Global Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · organigram.ca

1.670CAD+0.60%Mkt Cap: 170.46M $P/E: 2.77Today

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap170.46M $

Enterprise Value221.89M $

Revenue (TTM)225.16M $

Gross Profit65.70M $

Net Income (TTM)-18.03M $

Revenue/Share1.655 USD

Last Price1.670 CAD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees1.1K

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA68620P1018

Valuation

P/E (Trailing)2.77

P/E (Forward)50.38

PEG—

EV/EBITDA18.48

EV/Revenue0.99

P/S0.76

P/B0.46

EPS (TTM)0.60

EPS (Forward)0.03

52W Range

1.19525% of range3.090

52W High3.090 CAD

52W Low1.195 CAD

Profitability

Gross Margin34.81%

Oper. Margin5.04%

EBITDA Margin5.33%

Profit Margin-9.55%

ROE-7.09%

ROA-4.40%

Growth

Revenue Growth49.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.53M $

CapEx (TTM)12.42M $

FCF Margin0.14%

FCF Yield0.18%

Net Debt6.78M $

Net Debt/EBITDA0.56

Balance Sheet

Debt/Equity0.03

Current Ratio2.61

Quick Ratio0.94

Book Value/Sh3.593 CAD

Cash/Share0.0860 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:4

Split DateJul 7, 2023

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)3.120 CAD

Upside (mean)+86.8%

Target Range1.850 CAD – 4.000 CAD

CAD1.850+86.8% to meanCAD4.000

# Analysts5

Ownership

Shares Out.141.01M

Float94.22M

Insiders30.21%

Institutions6.47%

Short Interest

Short Ratio6.7d

Short % Out.1.07%

Shares Short1.66M

Short (prev mo.)2.21M

Technical

SMA 501.420 (+17.6%)

SMA 2001.877 (-11.0%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)276.76K

Avg Vol (10d)365.26K

Technical Indicators

RSI (14)64.9

MACD0.0848

MACD Signal0.0388

MACD Hist.+0.0460

BB Upper1.777 CAD

BB Middle1.427 CAD

BB Lower1.076 CAD

BB Width49.17%

ATR (14)0.0831 CAD

Vol Ratio (20d)0.88x